Full Text
What Factors May Impact the Likelihood of First Abbreviated New Drug Application (ANDA) Submission for a Reference Product?

Abstract

Authors

S Wittayanukorn M Rosenberg A Schick M Hu Z Wang A Babiskin L Zhao

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×